These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 69009)
1. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells. Billings P; Burakoff S; Dorf ME; Benacerraf B J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. Billings P; Burakoff S; Dorf ME; Benacerraf B J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex products restrict the adherence of cytolytic T lymphocytes to minor histocompatibility antigens or to trinitrophenyl determinants on schistosomula of Schistosoma mansoni. Vadas MA; Butterworth AE; Burakoff S; Sher A Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1982-5. PubMed ID: 88051 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells. Bradley SM; Kruisbeek AM; Singer A J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271 [TBL] [Abstract][Full Text] [Related]
5. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. Armerding D; Sachs DH; Katz DH J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236 [TBL] [Abstract][Full Text] [Related]
6. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells. Burakoff SJ; Germain RN; Benacerraf B J Exp Med; 1976 Dec; 144(6):1609-20. PubMed ID: 1087327 [TBL] [Abstract][Full Text] [Related]
7. Shared determinants between virus-infected and trinitrophenyl-conjugated H-2-identical target cells detected in cell-mediated lympholysis. Starzinski-Powitz A; Pfizenmaier K; Koszinowski U; Röllinghoff M; Wagner H Eur J Immunol; 1976 Sep; 6(9):630-4. PubMed ID: 63379 [TBL] [Abstract][Full Text] [Related]
8. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. Singer A; Kruisbeek AM; Andrysiak PM J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor. Germain RN; Dorf ME; Benacerraf B J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532 [TBL] [Abstract][Full Text] [Related]
10. Induction of I region-restricted hapten-specific cytotoxic T lymphocytes. Wagner H; Starzinski-Powitz A; Jung H; Röllinghoff M J Immunol; 1977 Oct; 119(4):1365-8. PubMed ID: 302282 [TBL] [Abstract][Full Text] [Related]
11. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes. Moser G; Burakoff SJ; Abbas AK J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761 [TBL] [Abstract][Full Text] [Related]
12. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region. Schmitt-Verhulst AM; Shearer GM J Exp Med; 1976 Dec; 144(6):1701-6. PubMed ID: 1087329 [TBL] [Abstract][Full Text] [Related]
13. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells. Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193 [TBL] [Abstract][Full Text] [Related]
14. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self). Arora PK; Hanna EE Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952 [TBL] [Abstract][Full Text] [Related]
15. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets. Forman J J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848 [TBL] [Abstract][Full Text] [Related]
16. Antigen receptors on major histocompatibility complex-restricted T lymphocytes. I. Preparation and characterization of syngeneic antisera against trinitrophenyl-activated T cell blasts and demonstration of their specificity for idiotypes on cytotoxic T lymphocytes. Krammer PH; Rehberger R; Eichmann K J Exp Med; 1980 May; 151(5):1166-87. PubMed ID: 6154768 [TBL] [Abstract][Full Text] [Related]
17. Expression of both I-A and I-E/C subregion antigens on accessory cells required for in vitro generation of cytotoxic T lymphocytes against alloantigens or TNBS-modified syngeneic cells. Pettinelli CB; Ahmann GB; Shearer GM J Immunol; 1980 Apr; 124(4):1911-6. PubMed ID: 6154084 [TBL] [Abstract][Full Text] [Related]
18. Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells. Billings P; Burakoff SJ; Dorf ME; Benacerraf B J Exp Med; 1978 Aug; 148(2):341-50. PubMed ID: 100567 [TBL] [Abstract][Full Text] [Related]
19. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants. Fujiwara H; Tsuchida T; Levy RB; Shearer GM J Immunol; 1982 Sep; 129(3):1189-93. PubMed ID: 6179996 [TBL] [Abstract][Full Text] [Related]
20. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex. Shearer GM; Rehn TG; Garbarino CA J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]